At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Regulatory status differs for medical use, retail use, and athletic competition
The latter concentration makes measurement easier: 0.3ml equals 300mcg, 0.4ml equals 400mcg, and so on
The changes promote conversion of stored fat into energy
What is the bioavailability of 5-Amino-1MQ
Army Corps of Engineers and consulting on large-scale systems for government and industry